semaglutide 5/1 mg/ml The Indian government has approved #NovoNordisk's obesity drug, Wegovy, for the treatment of #fattyliver disease. Novo Nordisk said the Central Drugs Standard Control Organisation (CDSCO) approved #Wegovy's 2.4 mg injection for What is your favorite? Semaglutide

Who Benefits Most Semaglutide is ideal for individuals with type 2 diabetes, insulin resistance, obesity, or weight-related metabolic conditions

Risks and benefits for taking any medication must be evaluated between an individual and a physician, he said

In one study of postmenopausal women, those on hormone therapy experienced greater weight loss with semaglutide than those not on HRT, possibly due to estrogens effects on metabolism and appetite regulation

When estrogen levels are too high, this tricks the body into thinking it's pregnant and prevent ovulation

2016 Dec 9;13:92

Any licensed physician or qualified advanced practice provider can prescribe GLP-1 medications